Oscar Health, Inc. OSCR
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
Revenue compounded at +90.8% a year over the five years to FY2025.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Each USD of equity lost 45 cents this year.
The 7-year record
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue $B | 11.7 | 9.2 | 5.9 | 4.0 | 1.8 | 0.5 | 0.5 |
| Operating income $B | −0.4 | 0.1 | −0.2 | −0.6 | −0.5 | −0.4 | −0.3 |
| EBITDA $B | −0.4 | 0.1 | −0.2 | −0.6 | −0.5 | −0.4 | −0.3 |
| Income tax $B | 0.0 | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | −0.4 | 0.0 | −0.3 | −0.6 | −0.6 | −0.4 | −0.3 |
| Free cash flow $B | 1.1 | 1.0 | −0.3 | 0.4 | −0.2 | 0.2 | −0.2 |
| EPS, diluted $ | −1.69 | 0.10 | −1.22 | −2.85 | −3.20 | −14.16 | −9.06 |
| Dividend / sh $ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — | — | — | — |
| ROE % | −44.5 | 2.8 | −32.0 | −53.2 | — | — | — |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 7 of the 7 fiscal years we could check. 26 checks were skipped: the balance sheet is not tagged before 2020. 12 checks were skipped: EPS is not tagged before 2019.